Blog

ニュース

404

藤内 章嘉
Commentary on Protein-Protein and Protein-Peptide Interactions, peptidomimetics and related topics in drug discovery.

藤内 章嘉

Akiyoshi Fujiuchi is responsible for efficacy pharmacology and preclinical research in PRISM BioLab. He has about 30 years of deep knowledge and experience in drug discovery, especially in vivo animal experiments, at RaQualia Pharma as well as Pfizer. He nominated development candidates from internal and external collaborative projects as a lead. He received his BS...

前田 倫宏

Michihiro Maeda joined PRISM BioLab as CFO / Corporate Director. After obtaining an Economics degree at Austin College, TX, he took on various Finance responsibilities including M&A / IR / operational turnaround at USEN, CFO at Abbott Japan and Finance lead at Aillis Inc., as well as IPO / Fund raising lead at Promethera Biosciences...

松田 祥平, Ph.D.

Yohei Matsuda is responsible for medicinal chemistry and technology platform development. Before joining PRISM BioLab, he worked as a medicinal chemist at Taisho Pharmaceutical Co., Ltd. and engaged in drug discovery research in various disease areas and drug discovery technology development. He was involved in many projects as a chemistry leader and contributed to the...

松下 岳史

Takeshi Matsushita is responsible for medicinal chemistry at PRISM BioLab. He started his career as a medicinal chemist at ONO Pharmaceutical Co., Ltd., where he experienced a wide range of drug discovery programs including GPCRs and kinases, and contributed to the discovery of several clinical candidates with disease areas including CNS. Prior to joining to...

大城 博行

Hiroyuki Ohshiro is responsible for in vitro pharmacology, MOA analysis, and new research projects. He has more than 20 years of experience in drug discovery research. Prior to joining PRISM BioLab, he was at RaQualia Phama and led as biology and manager many discovery projects. Hiroyuki worked at Pfizer R&D Japan, he contributed in many...

朴 煕万, Ph.D.

Dr. Hyi-Man Park oversees the research and development initiatives for PRISM BioLab as Head of the Research and Development Department. Prior to joining PRISM BioLab, he was the Head of Biology at RaQualia Pharma Inc., which is a spin-off from the Pfizer Research Center Japan. Before RaQualia, he was at the Novartis Institute for BioMedical...

Ivan Plavec, Ph.D.

Dr. Ivan Plavec serves as a Senior Advisor to PRISM BioLab responsible for alliance management and business development. He has over thirty years of experience in biotechnology and pharmaceutical industry and held positions of Chief Business Officer at ImaginAb, Inc., Vice President of Business Development at BioSeek, Inc. and Asterand plc, Vice President of Technology...

髙島 一, Ph.D.

Dr. Hajime Takashima is responsible for all aspects of chemistry and medicinal chemistry in PRISM BioLab. In addition to managing and promoting pipeline projects and collaboration projects with our partners, he oversees in silico drug design, compound management, and intellectual property management. His specialties are medicinal chemistry, organic chemistry, and computational chemistry. Before joinning in...

竹原 大

Dai Takehara joined PRISM in 2011 as CFO and succeeded CEO from a founder in 2016. Before joining PRISM BioLab, he was a management member of healthcare related startup companies, ZIOsoft and Advantage Risk Management. He started his career at Recruit Co., Ltd. He received an MBA from the Kellogg School of Management, and BS...

藤間 達哉, Ph.D.

Dr. Tatsuya Toma is responsible for synthesis and scaffold development as well as medicinal chemistry in PRISM BioLab. Before joining in PRISM BioLab, he had an academic career as an assistant professor at Nagoya University. His research involves total synthesis of complex natural products as well as chemical biology. He received his undergraduate and PhD...

Scroll to top
jaJapanese